INTRODUCTION
D-dimer, a high molecular weight fibrinogen derivative derived from the cleavage of cross-linked fibrin, reflects both thrombin production and activation of fibrinolysis (1) (2) (3) . Among healthy individuals, there is significant between-person variability of D-dimer concentration within the normal range (4) . Elevated D-dimer levels occur in various disorders in which the coagulation system is activated, such as acute venous thromboembolism, ischemic cardiovascular disease and cancer (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . A meta-analysis has suggested an independent 1.7 fold increased risk of coronary heart disease for the highest versus the lowest third of Ddimer levels (18) . In this context, D-dimer may represent the summation of pro-coagulant balance or genetic factors, the extent of subclinical atherosclerosis, or the presence of underlying coagulation disorders that predispose to coronary thrombosis (10) . Moderately elevated D-dimer reflects minor raising in blood coagulation, thrombin formation, and turnover of cross-linked intravascular fibrin and these increases may be relevant to coronary heart disease (10) .
Besides the cardiovascular setting, elevated D-dimer was associated with higher risk of total mortality in apparently healthy subjects (19) and in patients with different diseases (20, 21) . Systemic activation of haemostasis is frequently observed in cancer patients, even in the absence of thrombosis (22, 23) .
Moreover, this activation has been implicated in cancer progression, angiogenesis and metastatic spread (22) . Increased levels of D-dimer indicate a global activation of haemostasis and fibrinolysis, and was associated with poor overall survival and increased mortality risk in cancer patients (17) . These observations make plausible the hypothesis of a link between elevation of D-dimer and total mortality. However, the specificity of the relation of D-dimer with total mortality has been questioned, as the degree of correlation with cardiovascular risk factors and markers of inflammation is moderate (3, 19) .
In order to better understand the relation of D-dimer with all cause mortality, we analyzed the cohort of participants in the MOLI-SANI study.
METHODS

Study Participants
We included all individuals free of clinically recognized cardiovascular and cancer disease, recruited in the MOLI-SANI study (24) (25) (26) (27) (28) (29) (30) . Briefly, the MOLI-SANI project is a cohort study, started in March 2005.
Participants, men and women aged ≥ 35, living in Molise, a Southern Italian region, were randomly recruited from city-hall registries. Up to April 2010 24,325 subjects were recruited at baseline. We excluded participants with a previous personal history of cardiovascular disease (6%) or cancer (3%), those with missing value for D-dimer or other relevant variables (14%) or lost at follow-up (5%). The final study sample consisted of 17,639 individuals. The cohort was followed-up for mortality for any cause for a median of 4.2 years (max 6.5 y). Follow-up based on the mortality regional registry was from the baseline examination until death or 31 December 2011 for persons staying alive.
The ascertainment of vital status was carried out through linkage with demographic rosters, to identify the date of death. For deceased subjects, families were asked to confirm and about cause of death. Moreover, death certificates were retrieved; these report the initial and underlying causes of death and were coded according to the International Classification of Diseases, ninth Revision (ICD-9). In-hospital death were also checked through regional hospital discharge databases by record linkage to the MOLI-SANI database.
On 31/12/2011, in the whole MOLI-SANI cohort (n=24,325 subjects) a total of n=596 deaths were recorded.
The number of deaths in the sample (n=17,639) included in the present study was 280.
The MOLI-SANI study complies with the Declaration of Helsinki and was approved by the Catholic University ethical committee. All participants enrolled provided written informed consent.
Risk Factor Ascertainment
D-dimer was measured on fresh citrated plasma by an automated latex-enhanced immunoassay (HemosIL-IL, Milan). Quality control was maintained using internal laboratory standard in-house plasma pool. Inter and intra-day variability coefficients were 5.4% and 7.6%, respectively.
Statistical Methods
Hazard ratios of death for D-dimer, modeled as quartiles or continuous variables, were calculated using the following Cox proportional hazard models: (1) crude, (2) adjusted for baseline age and sex and (3) additionally adjusted for other risk factors: baseline body mass index, hypertensive, diabetics and dyslipidemic status, usual alcohol intake, smoking status, exercise, and score of social status. The data analysis was generated using SAS/STAT software, Version 9.1.3 of the SAS System for Windows©2009. SAS Institute Inc. and SAS are registered trademarks of SAS Institute Inc., Cary, NC, USA.
RESULTS
Baseline Characteristics
The baseline characteristics of the 17,639 subjects included in the analysis in relation to death are reported in Table 1 . Incidence of death was lower in women; subjects who died were older, had a higher prevalence of smoking, underweight, diabetes and abstention from alcohol than those who survived.
D-dimer and cardiovascular risk factors
As shown in Table 2 , D-dimer was positively associated with age, was lower in men than in women, and varied with smoking, body mass index, alcohol intake and dyslipidemia. D-dimer was also modestly but significantly associated with diastolic blood pressure, lipids, glucose, CRP and WBC.
D-dimer and deaths
Incidence of death increased from 1.1% to 2.8% according to quartiles of D-dimer (Table 3 ). In comparison with the lower quartile, the hazard ratio for death of the upper quartile was 2.86 (95%CI: 1.04 to 4.00) in univariable analysis, 1.54 (95%CI: 1.08 to 2.20) adjusted for age and sex and 1.46 (95%CI: 1.02 to 2.10) in multivariable analysis adjusted for age, sex, smoking, BMI, alcohol intake, hypertensive, diabetic or dyslipidemic status. The increase in the risk of death was confined to the upper quartile -in fact in none of the three models the second and the third quartile differed from the first. To better investigate the dose-response relationship between D-dimer and incidence of death the population was divided in 12 categories at increasing D-dimer and hazard ratios were calculated for each category with the lowest one acting as the reference. As depicted in the Figure, the relative risk of death was equal to one for all categories with the exception for the last three (when D-dimer was >221 ng/ml) in which it increased linearly. Following this observation, hazard ratios were re-calculated using the group of individuals with D-dimer <221 ng/ml acting as the reference group, while the remaining individuals were subdivided in tertiles (Table 4) . Multivariable HRs for mortality were 1.06, 1.45 and 1.97, respectively (P for trend <0.0001) across categories of increasing D-dimer. The association was slightly attenuated, but still significant (P for trend 0.0002), after further adjustment for white blood cell and C-reactive protein (Table 4) .
We failed to observe any statistically significant interaction in regulating risk of death among elevation of Ddimer and any of the risk factors listed in Table 4 (data not shown). In particular, we tested for additive or multiplicative interaction of D-dimer with age or sex, and we failed to observe statistical significant terms for interaction for each analysis performed. For example, in the model in Table 4 (adjusted for age, sex, smoking, BMI, alcohol intake, hypertensive, diabetic or dyslipidemic status), terms of interaction had P=0.56 (sex) and P=0.83 (age).
DISCUSSION
This study shows that in a large prospective cohort of an apparently healthy adult population, high D-dimer at baseline was independently associated with incidence of mortality for any cause. The association was evident only for D-dimer values higher than 221 ng/ml (corresponding to the upper quartile of the distribution); starting from this level the relative risk of death linearly increased up to doubling for values higher than 312 ng/ml. Previous smaller prospective studies also reported that higher levels of D-dimer are markers of increased total mortality (3, 11, (19) (20) (21) 31) . In particular our findings are in agreement with those of the MESA study performed in a multiethnic USA general healthy population (19) . In that cohort a statistically significant increase in the risk of total mortality was observed for a D-dimer higher than 210 ng/ml. In the MESA study the value of 210 ng/ml corresponded to the median of the distribution, whereas in the MOLI-SANI study it approximately identifies the upper quartile. This discrepancy may be attributed to the fact that subjects included in the USA study were older (mean age 62 years as compared with 55 years in MOLI-SANI), and D-dimer increases with age. Notably, in both studies the risk of death started to increase at values around 210-220 ng/ml, which are candidate to be the cut-off for defining "high risk value" of D-dimer if D-dimer would be considered in the future as a reliable biomarker of risk for total mortality.
In our population D-dimer showed a moderate correlation for several conventional risk factors and inflammation markers. When adjusting for potential confounders (age, sex, smoking, baseline evidence of diabetes, hypertension or dyslipidemia, alcohol intake and inflammation markers), the association was somewhat reduced but remained highly statistically significant (P for trend: 0.0002). The lack of a strong correlation between D-dimer and conventional risk factors for cardiovascular diseases and the fact that elevated D-dimer associates with total mortality independently from conventional risk factors suggest that Ddimer measurement should be considered as informative as other conventional risk factors, at least in a middle-aged Italian population.
The meaning of the link between D-dimer and mortality for any cause in apparently healthy adults is not fully understood (2, 10, 17) . It is reasonable to conceive that early elevation of D-dimer together with other inflammatory factors may contribute to the development or the severity of several chronic diseases, including cardiovascular disease and cancer, thus leading to augmented mortality. The impact of higher D-dimer on mortality from any cause leaves open the possibility that both an effect on cardiovascular and one on cancer death contribute to the observed result, as implied by the so-called "common soil hypothesis", which recognizes a number of common mechanisms and risk factors for ischemic vascular disorders and hormone-dependent tumors (22, 32, 33) . Cancer is in fact frequently associated with activation of the haemostatic system and the extent of this activation has been reported to correlate with a more advanced tumor stage, with unfavorable outcomes and prognosis (32, 33) .
Nonetheless we may also consider that D-dimer itself is not a causal factor but it is a marker for other factors related to the pathophysiology of thrombosis or cancer, and elevated D-dimer may reflect currently unknown haemostatic or cancer disorders. D-dimer has high heritability and this fact supports the notion that D-dimer reflects genetic factors (34) . Nevertheless D-dimer might reflect other environmental risk factors for thrombosis, as inflammatory markers (15) . The possibility that D-dimer predicts pro-thrombotic states is suggested by the rapid normalization of D-dimer values after cardio-version (35) or warfarin treatment (36) in patients with atrial fibrillation.
Nonetheless, a reverse causality bias cannot be excluded, as tumor (22, 23, 32) and other chronic conditions will increase intravascular coagulation or elevation of markers of haemostasis and inflammation (12) .
Lastly, residual confounding by factors not measured or adjusted for, may explain the observed link between D-dimer and total mortality.
Limitations
Data from the MOLI-SANI study do not include at the moment information on specific cause of death or incidence of non fatal events. These data need rigorous processes of validation, that are ongoing. However, our findings concerning a clear association of high levels of D-dimer with total mortality, in agreement with a previous smaller study (19) , deserves appropriate dissemination. Another limitation of our study is the relatively small number of events and the short follow-up period. Moreover, similarly to several previous epidemiologic studies, we had only a single baseline measure of D-dimer; biologic variability, related to imprecision of single measurement, usually tends to weaken the measured associations.
Conclusions
In conclusion, in a apparently healthy population cohort of middle-aged men and women, elevated baseline D-dimer was related to mortality for any cause, independently from conventional risk factors or markers of inflammation. Measurement of D-dimer may lead to a practical improvement of the current risk stratification criteria for mortality. Further studies are required to test this hypothesis. 
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METHODS
Study Participants
Participants, men and women aged ≥35, living in Molise, a Southern Italian region, were randomly recruited from city-hall registries. Up to April 2010 24,325 subjects were recruited at baseline. Exclusion criteria were pregnancy at the time of recruitment, disturbances in understanding or willingness, current poly-traumas or coma, or refusal to sign the informed consent. We excluded participants with a previous personal history of cardiovascular disease (heart attack, angina, stroke, transient ischemic attack, coronary bypass, angioplasty, or other cardiovascular surgery, 6%) or cancer (3%), those with missing value for D-dimer or other relevant variables (14%) or lost at follow-up (5%). The final study sample consisted of 17,639 individuals. The mean age of subjects was 55±11 years and 47% were men. The cohort was followed-up for mortality for any cause for a median of 4.2 years (max 6.5 y). Follow-up based on the mortality regional registry was from the baseline examination until death or 31 December 2011 for persons staying alive.
Risk Factor Ascertainment
Cigarette smoking was defined by self-report of currently smoking every day or some days and having smoked >100 cigarettes in their lifetime. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Socio-economic status was defined by a score based on 6 variables (education, housing, ratio between the number of live-in partners and the number of rooms -both current and in the childhood -and availability of hot water at home in the childhood); the highest the score, the highest the level of socio-economic status. Physical activity was assessed by a structured questionnaire and expressed as
